Page 24 - Marne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Drugs, counterfeit goods and fraud: French customs report rises

Drugs, counterfeit goods and fraud: French customs report rises
connexionfrance.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from connexionfrance.com Daily Mail and Mail on Sunday newspapers.

Schleswig holsteinPoitou charentesÎe de franceUnited kingdomHaute normandieLe havreOlivier dussoptPublic accounts minister olivierTokyo olympicSustainability week

Remembering architect Ricardo Bofill (1939-2022)

Spanish architect Ricardo Bofill passed away, and we honour his memory revisiting his work and rich career, including projects such as The Red Wall

Schleswig holsteinFrance generalGrand casablancaSouth koreaUnited statesComunidad autonoma de catalunaSouth koreanMuralla rojaRicardo bofillLes espacesSebastian weissRicardo emilioMohammed vi polytechnic universityBarcelona national theatre of cataloniaRicardo bofill taller de arquitecturaRed wall

Theradiag: Signing of a Distribution Agreement with BIOSYNEX of Their AMPLIQUICK SARS-CoV-2 PCR Test

13.01.2022 - Regulatory News: THERADIAG (ISIN : FR0004197747, Mnémonique : ALTER), a company specializing in in vitro diagnostics of autoimmune diseases and theranostics, and BIOSYNEX (ISIN : FR0011005933, Mnémonique : ALBIO), leader on the Rapid Diagnostic Test .

Schleswig holsteinFrance generalIllkirch graffenstadenUniversity hospitalsEuronext growth parisRapid diagnostic tests

THERADIAG Announces Its 2022 Financial Calendar

Regulatory News: THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics of autoimmune diseases and theranostics, today announces its schedule

Schleswig holsteinFrance generalPierre laurentFinancial communications investor relationsRegulatory newsYear annual revenueYear resultsGeneral meetingHalf salesHalf resultsEuronext growth parisManaging directorCommunications investor relations

THERADIAG Announces the Launch of 4 New i-Tracker Kits and the Validation of a New Parameter in the United States

Regulatory News: THERADIAG (ISIN: FR0004197747, Ticker: ALTER) (Paris:ALTER), a company specializing in in vitro diagnostics and Theranostics, today announces the launch of four additional kits in

Schleswig holsteinUnited statesFrance generalTheradiag optimabs infliximabPierre laurentDrug administrationFinancial communications investor relationsRegulatory newsTracker golimumabTracker anti golimumabTracker rituximabTracker anti rituximabFederal drug administrationOptimabs infliximabEuronext growth parisManaging director